A detailed history of Octagon Capital Advisors LP transactions in Regulus Therapeutics Inc. stock. As of the latest transaction made, Octagon Capital Advisors LP holds 4,263,701 shares of RGLS stock, worth $6.27 Million. This represents 1.62% of its overall portfolio holdings.

Number of Shares
4,263,701
Previous 4,263,701 -0.0%
Holding current value
$6.27 Million
Previous $7.63 Million 12.29%
% of portfolio
1.62%
Previous 1.76%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.79 - $2.8 $7.63 Million - $11.9 Million
4,263,701 New
4,263,701 $7.63 Million

Others Institutions Holding RGLS

About Regulus Therapeutics Inc.


  • Ticker RGLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,634,400
  • Market Cap $21.5M
  • Description
  • Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...
More about RGLS
Track This Portfolio

Track Octagon Capital Advisors LP Portfolio

Follow Octagon Capital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Octagon Capital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Octagon Capital Advisors LP with notifications on news.